Clinical trial
Tumor Heterogeneity in Diffuse Large B-cell Lymphoma in Relation to CNS Involvement and Cell-free DNA
NCT04763148 is registered in ClinicalTrials.gov with Herlev Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tumor Heterogeneity in Diffuse Large B-cell Lymphoma in Relation to CNS Involvement and Cell-free DNA
- Lead sponsor
- Herlev Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 12, 2022
- Completion date
- March 1, 2023
- Enrollment
- 26 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.